Value-Based Voices welcomes Maria Ghazal, JD, MA, President & CEO, Healthcare Leadership Council, for a dynamic conversation spanning Medicare Advantage, prior authorization reform, artificial intelligence, Most Favored Nation drug pricing, and the growing competitive pressure from China in biopharmaceutical innovation.

During this conversation, hosted by Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies, and AVBCC Board Member, Maria shares insights from HLC’s diverse membership of 60+ C-suite leaders and explains how consensus-driven policy can shape the future of value-based care.

Together, Jayson and Maria explore:

• The evolving landscape of Medicare Advantage

• HLC’s newly released AI policy recommendations

• The implications of Most Favored Nation drug pricing and why affordability and innovation must not be treated as competing goals

• The rapid rise of China in biopharmaceutical development and AI-enabled healthcare—and what the U.S. must do to maintain leadership

• How HLC builds consensus across one of the most diverse memberships in healthcare

This episode offers a candid, cross-sector look at the policies, pressures, and opportunities that will define the next decade of value-based care.

Listen and subscribe for more conversations shaping the future of oncology and value-based healthcare.

#ValueBasedCare #MedicareAdvantage #HealthcarePolicy #AIinHealthcare #AI #Innovation #AVBCC #HLC #China #biopharma

Resources:

Association for Value-Based Cancer Care (AVBCC): https://avbcc.org/

Healthcare Leadership Council (HLC): https://www.hlc.org/

Medicare Advantage cost analysis & MedPAC rebuttal: https://www.hlc.org/news/hlc-leader-reacts-to-latest-medpac-report-to-congress-on-medicare-payment-policy/

AI Federal Framework Preliminary Report: https://www.hlc.org/news/healthcare-sector-calls-for-unified-federal-framework-to-unlock-ais-full-potential-for-patients/

Improving Seniors’ Timely Access to Care Act: https://www.congress.gov/bill/119th-congress/house-bill/3514

CMS prior authorization reforms: https://www.cms.gov/initiatives/burden-reduction/overview/interoperability/policies-regulations/cms-interoperability-standards-prior-authorization-drugs-proposed-rule-cms-0062-p

Connect with our Guests:

Maria Ghazal, JD, MA: https://www.linkedin.com/in/maria-ghazal/

Jayson Slotnik: https://www.linkedin.com/in/jayson-slotnik-3932305/

Contact Value-Based Voices

- Follow AVBCC on LinkedIn

- View our podcast lineup

- Contact us at info@avbcc.org

Thanks for listening!